Ignite Creation Date:
2024-05-05 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00406081
Status:
COMPLETED
Last Update Posted:
2017-01-11
First Post:
2006-11-30
Brief Title:
Immune Response to Varicella Vaccination in Children With Atopic Dermatitis
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Study Overview
Official Title:
Immune Response to Varicella Vaccination in Subjects With Atopic Dermatitis Compared to Nonatopic Controls VAR 05
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Atopic dermatitis AD causes people to be susceptible to skin infection and inflammations The purpose of this study is to determine the immune response to chicken pox vaccine in children with or without AD who received the vaccine 2 to 16 weeks prior to the study visit
Detailed Description:
AD is a chronic inflammatory skin disorder characterized by recurrent viral skin infections Children with AD given the smallpox vaccine could develop a life-threatening condition known as eczema vaccinatum This immune response is not currently understood The purpose of this study is to understand the immune response to a viral vaccine in children with AD This will be accomplished by studying immune response to the chicken pox vaccine in children with AD in comparison to those without AD
This study will consist of one study visit occurring about 2 to 16 weeks after the child received the chicken pox vaccination During this visit physical and skin exams will occur Personal and family medical histories and blood collection will also occur The chicken pox vaccine will not be given as a part of this study Subjects will receive the results of radioallergosorbent RAST testing that will tell if they are allergic to some common items eg mold grass
This study will consist of one study visit occurring about 2 to 16 weeks after the child received the chicken pox vaccination During this visit physical and skin exams will occur Personal and family medical histories and blood collection will also occur The chicken pox vaccine will not be given as a part of this study Subjects will receive the results of radioallergosorbent RAST testing that will tell if they are allergic to some common items eg mold grass
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Contract No HHSN266200400029C | None | None | None |